Avisi Technologies

Founded in March 2017, Avisi is a medical devices company developing VisiPlate, a nanotechnology-enabled ocular implant for treating glaucoma. Open-angle glaucoma (OAG) is the leading cause of irreversible blindness in the world. OAG affects nearly 4 million people in the US and over 80 million people globally. In OAG patients, excess fluid builds up inside the eye, putting pressure on and permanently damaging the optic nerve.